▟ Vinebot intrinsic value, daily

← back

JPM JPMorgan Chase

bank · valued with opus medium conviction · deep-dived 2026-11-06

SELL
Intrinsic value$200.93
Price (at call)$337.34
Margin of safety -40.4%
vs market (rating basis) -22.0%

Fortress franchise, but 2.6x book assumes peak 19% ROE lasts; normalized 16% supports about $197.

The story

JPMorgan is the best-run US universal bank, with scale in deposits, card, IB and payments, a fortress CET1 position, and a multi-year run of 17-20% returns on equity. Trailing ROE of 19.3% reflects elevated net interest income, benign credit costs and strong markets revenue, which looks like a late-cycle peak rather than a steady state. At about 2.6x book, the market is pricing near-peak returns as permanent and leaving little room for credit normalization, lower rates or a capital-markets downturn.

Nothing material has changed since 2026-10-20. Price is up about 1%, and the trailing 19.3% ROE confirms continued peak conditions rather than a new structural level. I keep 16% as the through-the-cycle ROE, which credits JPM's best-in-class franchise but assumes credit losses and NII revert. Book grows 7% near term from retained earnings net of buybacks and fades to 4%, below the 4.84% risk-free rate. Beta stays at the 1.1 industry anchor, and failure risk is minimal given G-SIB capital and liquidity.

Value drivers

Return on equity (normalized)16.0%
Book-value growth (Y1)7.0%
Terminal book growth4.0%
Beta1.10
Failure probability0.5%
Cost of equity9.8%

Valuation bridge

PV of excess returns114.46B
PV of terminal excess79.42B
Equity value533.59B
÷ shares → per share$200.93

Projected excess returns on equity

YrBook equityROEExcess returnPV
1342.39B 16.0%21.27B 19.38B
2366.36B 15.5%21.05B 17.46B
3390.78B 15.1%20.62B 15.58B
4415.53B 14.6%19.98B 13.75B
5440.47B 14.1%19.12B 11.99B
6465.43B 13.7%18.02B 10.29B
7490.25B 13.2%16.69B 8.68B
8514.76B 12.7%15.11B 7.16B
9538.78B 12.3%13.30B 5.74B
10562.13B 11.8%11.24B 4.42B

Key risks

  • Credit normalization in card and commercial real estate pushes provisions well above current run-rate
  • Rate cuts compress net interest income from a peak level while deposit costs lag
  • Basel III endgame or G-SIB surcharge changes raise required capital and dilute ROE
  • Upside risk to the thesis: ROE sustains 18%+ through a full cycle, justifying a premium multiple

Catalysts

  • Final Basel III endgame capital rules (a softer version frees excess capital for buybacks)
  • Q4 2026 results and 2027 NII and expense guidance
  • Leadership succession clarity after Dimon

History

DatePriceIntrinsicMoSRating
2026-11-06$337.34 $200.93 -40.4% SELL
2026-10-20$333.53 $196.61 -41.1% HOLD
2026-10-01$330.83 $194.27 -41.3% HOLD
2026-09-14$356.23 $198.31 -44.3% HOLD
2026-08-26$356.69 $189.57 -46.9% HOLD
2026-08-07$356.30 $188.59 -47.1% HOLD
2026-07-20$341.10 $187.77 -45.0% HOLD
2026-07-01$327.33 $187.28 -42.8% HOLD
2026-06-23$334.14 $186.28 -44.3% HOLD